I build active repositories of knowledge—archives that grow over time, adapt to changing contexts, and present information in accessible formats. They are designed to be revisited, reinterpreted, and to remain relevant long after their initial release.
For Global Justice Now, I developed a CMS-based website for Two Worlds, a documentary series exposing how, from the HIV crisis to Ebola, pharmaceutical corporations have prioritised profit over lives. The platform was built to expand with future films and participatory resources, creating a dynamic archive that preserves testimony, documents resistance, and fosters collective memory.
The central image shows a pill split in two, its lower half shattered like a fractured globe. It symbolises medicine and inequality, highlighting the unequal global access to essential treatments.
Drawing from the aesthetics of medication packaging, the typography and layout adopt a modernist, pared-back style—reversing the usual black-on-white to white-on-black for drama and urgency.
The poster integrates the split-pill motif with bold, high-contrast typography to convey both urgency and gravity. The layout balances a clean, pharmaceutical feel with activist energy, using space strategically to highlight the film title and subtitle while supporting multiple stills or imagery variations. The design also works in square and digital-friendly formats for social media applications.
I developed a CMS-based website to host Two Worlds, ensuring it could grow as the documentary series expanded. The platform accommodates future films and participatory resources, making it a dynamic, evolving archive. The site structure and interface prioritise clarity, accessibility, and long-term relevance, while the design mirrors the series’ visual identity for consistency across media.
The films feature testimonies from activists, patients, and health workers challenging an unjust system. They expose the flaws of the current model, from big pharma’s profiteering on life-saving HIV drugs to neglecting diseases in lower-income countries. At the same time, they highlight efforts to create alternatives: scientists developing new models and activists pushing for fairer access to medicines.